ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301)

Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

NCT00104013 ·Status: COMPLETED ·Phase: PHASE3

18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

NCT00103649 ·Status: COMPLETED ·Phase: PHASE3

ELND005 in Patients With Mild to Moderate Alzheimer's Disease

NCT00568776 ·Status: COMPLETED ·Phase: PHASE2

Allopregnanolone for Mild Cognitive Impairment Due to Alzheimer's Disease or Mild AD

NCT02221622 ·Status: COMPLETED ·Phase: PHASE1

Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease

NCT04838301 ·Status: RECRUITING ·Phase: PHASE2

Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil

NCT01955161 ·Status: COMPLETED ·Phase: PHASE3

The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility

NCT00571064 ·Status: COMPLETED ·Phase: PHASE4

Optimal Medication Management in Alzheimer's Disease and Dementia

NCT03984396 ·Status: COMPLETED ·Phase: NA

Clinical Trial to Determine Tolerable Dosis of Vorinostat in Patients With Mild Alzheimer Disease

NCT03056495 ·Status: TERMINATED ·Phase: PHASE1

Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients

NCT01097096 ·Status: COMPLETED ·Phase: PHASE2

Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects

NCT06304883 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease

NCT00722046 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-552 Capsules Moves Through the Body of Participants Aged 50 to 90 Years With Mild Alzheimer's Disease

NCT05771428 ·Status: COMPLETED ·Phase: PHASE2

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

NCT00884507 ·Status: COMPLETED ·Phase: PHASE2

A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease

NCT01766336 ·Status: TERMINATED ·Phase: PHASE2

Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease

NCT00501111 ·Status: COMPLETED ·Phase: PHASE2

SEMA4D Blockade Safety and Brain Metabolic Activity in Alzheimer's Disease (AD)

NCT04381468 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease

NCT00912288 ·Status: TERMINATED ·Phase: PHASE3

Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study

NCT00495820 ·Status: COMPLETED ·Phase: PHASE4

AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer Disease

NCT02284906 ·Status: TERMINATED ·Phase: PHASE3

4 Week, Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease

NCT01039701 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study for Subjects With Mild-to-Moderate Alzheimer's Disease

NCT00948909 ·Status: COMPLETED ·Phase: PHASE2

Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)

NCT01466088 ·Status: COMPLETED ·Phase: PHASE2

ADVANCE Study: Alzheimer Disease eVAluation iN Clinical PracticE

NCT01772095 ·Status: COMPLETED

Acute Effects Of Donepezil On Brain Perfusion And Memory In Subjects With Cognitive Impairment And Mild Alzheimer's Disease

NCT01082965 ·Status: TERMINATED ·Phase: NA